US Stock MarketDetailed Quotes
IGMS IGM Biosciences
- 9.400
- +1.750+22.88%
Close Apr 26 16:00 ET
- 9.410
- +0.010+0.11%
Post 18:26 ET
554.16MMarket Cap-1995P/E (TTM)
9.480High7.410Low468.94KVolume7.740Open7.650Pre Close4.12MTurnover3.97%Turnover RatioLossP/E (Static)58.95MShares17.70052wk High2.73P/B110.94MFloat Cap3.81052wk Low--Dividend TTM11.80MShs Float133.000Historical High--Div YieldTTM27.06%Amplitude3.810Historical Low8.784Avg Price1Lot Size
IGM Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -3,184.32%-192.23M | -26.81%-48.01M | 0.72%-40.12M | -147.71%-53.11M | -31.13%-51M | 95.32%-5.85M | -7.25%-37.86M | -17.46%-40.41M | 512.03%111.31M | -37.60%-38.89M |
| Net income from continuing operations | -11.45%-246.42M | -15.44%-60.7M | -6.81%-61.99M | -9.95%-64.42M | -14.29%-59.31M | -33.87%-221.1M | -3.82%-52.58M | -31.41%-58.04M | -51.35%-58.6M | -63.99%-51.89M |
| Depreciation and amortization | 36.25%8.28M | 14.91%2.18M | 49.70%2.26M | 50.48%2.17M | 35.95%1.66M | 35.48%6.08M | 45.66%1.9M | 37.81%1.51M | 2.19%1.44M | 81.87%1.22M |
| Other non cash items | 26.54%15.19M | -27.37%3.9M | 81.83%5.26M | 8.73%3M | 208.66%3.03M | 335.98%12.01M | 739.22%5.37M | 128.13%2.9M | 1,495.38%2.76M | 45.98%981K |
| Change In working capital | -104.31%-6.69M | 61.57%-643K | 42.69%4.74M | -103.79%-5.85M | -471.76%-4.94M | 2,306.86%155.17M | -135.50%-1.67M | 223.35%3.32M | 3,434.41%154.38M | 76.41%-864K |
| -Change in prepaid assets | 376.60%1.71M | 509.75%1.64M | 274.82%3.73M | -283.72%-3.6M | -106.22%-58K | 110.89%359K | 75.08%-400K | -1,677.50%-2.13M | 111.33%1.96M | 137.32%933K |
| -Change in payables and accrued expense | -139.30%-4.21M | -567.92%-1.06M | -79.12%1.66M | -134.50%-1.31M | -296.60%-3.5M | -19.05%10.7M | -102.20%-159K | 300.00%7.96M | -8.08%3.79M | -680.53%-882K |
| -Change in other current assets | 120.06%194K | 45.00%174K | 112.11%136K | 442.86%38K | -631.03%-154K | -98.16%-967K | 195.24%120K | -1,321.52%-1.12M | -87.27%7K | 108.58%29K |
| -Change in other current liabilities | 41.34%-2.26M | 13.81%-743K | 73.78%-274K | 46.57%-537K | 25.00%-708K | -29.05%-3.86M | -10.51%-862K | -37.14%-1.05M | -36.73%-1.01M | -32.77%-944K |
| -Change in other working capital | -101.43%-2.13M | -75.00%-651K | -53.78%-509K | ---448K | ---522K | --148.93M | ---372K | ---331K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -3,184.32%-192.23M | -26.81%-48.01M | 0.72%-40.12M | -147.71%-53.11M | -31.13%-51M | 95.32%-5.85M | -7.25%-37.86M | -17.46%-40.41M | 512.03%111.31M | -37.60%-38.89M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 130.29%68.36M | 21.89%-14.69M | 621.58%19.55M | 96.56%-6.33M | 465.51%69.82M | -1,559.44%-225.64M | -939.78%-18.81M | 92.04%-3.75M | -987.94%-183.98M | -148.23%-19.1M |
| Net PPE purchase and sale | -21.31%-12.38M | 46.27%-1.45M | -13.72%-3.08M | -114.65%-3.91M | -32.25%-3.94M | 22.94%-10.21M | -52.86%-2.7M | -20.70%-2.71M | 42.35%-1.82M | 50.98%-2.98M |
| Net investment purchase and sale | 137.48%80.74M | 17.81%-13.25M | 2,282.45%22.63M | 98.68%-2.41M | 557.40%73.76M | -850.52%-215.44M | -502.60%-16.12M | 97.69%-1.04M | -862.75%-182.16M | -135.30%-16.13M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 130.29%68.36M | 21.89%-14.69M | 621.58%19.55M | 96.56%-6.33M | 465.51%69.82M | -1,559.44%-225.64M | -939.78%-18.81M | 92.04%-3.75M | -987.94%-183.98M | -148.23%-19.1M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -47.55%115.07M | -16.60%402K | 14,929.97%44.64M | -67.99%69.95M | 4.17%75K | 8,760.34%219.38M | -67.67%482K | -72.27%297K | 662,315.15%218.53M | 235.85%72K |
| Net common stock issuance | -47.90%113.56M | --0 | --44.62M | ---- | ---- | --217.99M | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | 7.81%1.5M | -16.60%402K | -92.59%22K | 108.07%1.01M | -43.61%75K | -65.39%1.4M | -70.39%482K | -79.85%297K | -14.36%483K | -63.56%133K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 85.41%-61K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -47.55%115.07M | -16.60%402K | 14,929.97%44.64M | -67.99%69.95M | 4.17%75K | 8,760.34%219.38M | -67.67%482K | -72.27%297K | 662,315.15%218.53M | 235.85%72K |
| Net cash flow | ||||||||||
| Beginning cash position | -9.04%121.92M | -1.51%175.41M | -31.82%151.34M | 85.01%140.82M | -9.04%121.92M | -44.40%134.04M | 7.55%178.11M | -9.79%221.97M | -69.84%76.12M | -44.40%134.04M |
| Current changes in cash | 27.30%-8.81M | -10.88%-62.3M | 154.87%24.07M | -92.79%10.52M | 132.63%18.9M | 88.68%-12.12M | -77.98%-56.19M | 45.47%-43.86M | 2,405.29%145.86M | -612.75%-57.92M |
| End cash Position | -7.22%113.11M | -7.22%113.11M | -1.51%175.41M | -31.82%151.34M | 85.01%140.82M | -9.04%121.92M | -9.04%121.92M | 7.55%178.11M | -9.79%221.97M | -69.84%76.12M |
| Free cash flow | -1,174.13%-204.61M | -21.95%-49.46M | -0.19%-43.2M | -152.08%-57.02M | -31.21%-54.93M | 88.38%-16.06M | -9.42%-40.55M | -17.66%-43.12M | 462.82%109.48M | -21.93%-41.87M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
